Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arden Partners is a UK-based institutional stockbroker and corporate finance advisory firm that provides a range of financial services to small and mid-cap companies. While not a biotechnology company itself, Arden Partners maintains a significant focus on the healthcare and life sciences sectors, providing specialized equity research, brokerage, and corporate advisory services to firms in these industries. The company assists life science entities with capital raising, IPOs, and secondary fundraisings on markets such as the London Stock Exchange's AIM. In 2022, Arden Partners was acquired by the Australian financial services group Shaw and Partners, which is part of the Jarden group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arden Partners.